{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T13:12:20Z","timestamp":1784207540906,"version":"3.55.0"},"reference-count":88,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Describe developments in the etiological understanding of Tourette syndrome.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Tourette syndrome is a complex heterogenous clinical syndrome, which is not a unitary entity. Pathophysiological models describe gamma-aminobutyric acid-ergic-associated disinhibition of cortico-basal ganglia motor, sensory and limbic loops. MRI studies support basal ganglia volume loss, with additional white matter and cerebellar changes. Tourette syndrome cause likely involves multiple vulnerability genes and environmental factors. Only recently have some vulnerability gene findings been replicated, including histidine decarboxylase and neurexin 1, yet these rare variants only explain a small proportion of patients. Planned large genetic studies will improve genetic understanding. The role of inflammation as a contributor to disease expression is now supported by large epidemiological studies showing an association with maternal autoimmunity and childhood infection. Investigation of blood cytokines, blood mRNA and brain mRNA expression support the role of a persistent immune activation, and there are similarities with the immune literature of autistic spectrum disorder. Current treatment is symptomatic, although there is a better appreciation of factors that influence treatment response.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>At present, therapeutics is focused on symptom-based treatments, yet with improved etiological understanding, we will move toward disease-modifying therapies in the future.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mop.0000000000000546","type":"journal-article","created":{"date-parts":[[2017,9,15]],"date-time":"2017-09-15T01:40:11Z","timestamp":1505439611000},"page":"665-673","source":"Crossref","is-referenced-by-count":54,"title":["Tics and Tourette: a clinical, pathophysiological and etiological review"],"prefix":"10.1097","volume":"29","author":[{"given":"Russell C.","family":"Dale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20231208","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S2215-0366(14)00132-1","article-title":"A personal 35 year perspective on Gilles de la Tourette syndrome: prevalence, phenomenology, comorbidities, and coexistent psychopathologies","volume":"2","author":"Robertson","year":"2015","journal-title":"Lancet Psychiatry"},{"key":"R3-20231208","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pediatrneurol.2012.05.002","article-title":"Prevalence of tic disorders: a systematic review and meta-analysis","volume":"47","author":"Knight","year":"2012","journal-title":"Pediatr Neurol"},{"key":"R4-20231208","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.2147\/NDT.S72284","article-title":"Are there distinct subtypes in Tourette syndrome? Pure-Tourette syndrome versus Tourette syndrome-plus, and simple versus complex tics","volume":"11","author":"Eapen","year":"2015","journal-title":"Neuropsychiatr Dis Treat"},{"key":"R5-20231208","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1469-8749.2008.03135.x","article-title":"Coprophenomena in Tourette syndrome","volume":"51","author":"Freeman","year":"2009","journal-title":"Dev Med Child Neurol"},{"key":"R6-20231208","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1001\/jamapsychiatry.2014.2650","article-title":"Lifetime prevalence, age of risk, and genetic relationships of comorbid psychiatric disorders in Tourette syndrome","volume":"72","author":"Hirschtritt","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"R7-20231208","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1080\/13651501.2017.1291822","article-title":"Parsing the phenotype of obsessive\u2013compulsive tic disorder (OCTD): a multidisciplinary consensus","volume":"21","author":"Dell\u2019Osso","year":"2017","journal-title":"Int J Psychiatry Clin Pract"},{"key":"R8-20231208","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.jaac.2017.05.002","article-title":"Autism spectrum symptoms in a Tourette's disorder sample","volume":"56","author":"Darrow","year":"2017","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"R9-20231208","first-page":"213","article-title":"Non-motor aspects of tic disorders \u2013 new developments","volume":"7","author":"Ruhrman","year":"2016","journal-title":"Front Psychiatry"},{"key":"R10-20231208","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/WCO.0000000000000356","article-title":"Tics and Tourette's: update on pathophysiology and tic control","volume":"29","author":"Ganos","year":"2016","journal-title":"Curr Opin Neurol"},{"key":"R11-20231208","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1002\/mds.26304","article-title":"Pathophysiology of tic disorders","volume":"30","author":"Yael","year":"2015","journal-title":"Mov Disord"},{"key":"R12-20231208","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/cne.22206","article-title":"Decreased number of parvalbumin and cholinergic interneurons in the striatum of individuals with Tourette syndrome","volume":"518","author":"Kataoka","year":"2010","journal-title":"J Comp Neurol"},{"key":"R13-20231208","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.biopsych.2014.07.018","article-title":"Transcriptome analysis of the human striatum in Tourette syndrome","volume":"79","author":"Lennington","year":"2016","journal-title":"Biol Psychiatry"},{"key":"R14-20231208","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s13311-013-0215-4","article-title":"Treatment of Tourette syndrome","volume":"11","author":"Kurlan","year":"2014","journal-title":"Neurotherapeutics"},{"key":"R15-20231208","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1001\/archpsyc.60.4.415","article-title":"Basal ganglia volumes in patients with Gilles de la Tourette syndrome","volume":"60","author":"Peterson","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"R16-20231208","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1002\/hbm.23146","article-title":"Combining tract- and atlas-based analysis reveals microstructural abnormalities in early Tourette syndrome children","volume":"37","author":"Wen","year":"2016","journal-title":"Hum Brain Mapp"},{"key":"R17-20231208","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/ana.21918","article-title":"Cerebellar morphology in Tourette syndrome and obsessive\u2013compulsive disorder","volume":"67","author":"Tobe","year":"2010","journal-title":"Ann Neurol"},{"key":"R18-20231208","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jocrd.2014.06.003","article-title":"The inheritance of tourette disorder: a review","volume":"3","author":"Pauls","year":"2014","journal-title":"J Obsessive Compuls Relat Disord"},{"key":"R19-20231208","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3389\/fnins.2016.00351","article-title":"The genetic etiology of Tourette syndrome: large-scale collaborative efforts on the precipice of discovery","volume":"10","author":"Georgitsi","year":"2016","journal-title":"Front Neurosci"},{"key":"R20-20231208","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3389\/fnins.2016.00384","article-title":"TS-EUROTRAIN: a European-wide investigation and training network on the etiology and pathophysiology of Gilles de la Tourette syndrome","volume":"10","author":"Forde","year":"2016","journal-title":"Front Neurosci"},{"key":"R21-20231208","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1056\/NEJMoa0907006","article-title":"l-histidine decarboxylase and Tourette's syndrome","volume":"362","author":"Ercan-Sencicek","year":"2010","journal-title":"N Engl J Med"},{"key":"R22-20231208","doi-asserted-by":"crossref","first-page":"6599","DOI":"10.1073\/pnas.1704547114","article-title":"Histamine modulation of the basal ganglia circuitry in the development of pathological grooming","volume":"114","author":"Rapanelli","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R23-20231208","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.biopsych.2011.09.034","article-title":"Rare copy number variants in tourette syndrome disrupt genes in histaminergic pathways and overlap with autism","volume":"71","author":"Fernandez","year":"2012","journal-title":"Biol Psychiatry"},{"key":"R24-20231208","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.bbi.2016.07.002","article-title":"Histamine regulation of microglia: gene\u2013environment interaction in the regulation of central nervous system inflammation","volume":"57","author":"Frick","year":"2016","journal-title":"Brain Behav Immun"},{"key":"R25-20231208","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1126\/science.1116502","article-title":"Sequence variants in SLITRK1 are associated with Tourette's syndrome","volume":"310","author":"Abelson","year":"2005","journal-title":"Science"},{"key":"R26-20231208","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3389\/fnins.2016.00428","article-title":"Targeted re-sequencing approach of candidate genes implicates rare potentially functional variants in Tourette syndrome etiology","volume":"10","author":"Alexander","year":"2016","journal-title":"Front Neurosci"},{"key":"R27-20231208","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1212\/WNL.0b013e3181e0f147","article-title":"Tourette syndrome is associated with recurrent exonic copy number variants","volume":"74","author":"Sundaram","year":"2010","journal-title":"Neurology"},{"key":"R28-20231208","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.biopsych.2015.08.027","article-title":"Association of AADAC deletion and Gilles de la Tourette syndrome in a large European cohort","volume":"79","author":"Bertelsen","year":"2016","journal-title":"Biol Psychiatry"},{"key":"R29-20231208","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.jaac.2014.04.022","article-title":"Copy number variation in obsessive\u2013compulsive disorder and tourette syndrome: a cross-disorder study","volume":"53","author":"McGrath","year":"2014","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"R30-20231208","doi-asserted-by":"crossref","first-page":"e59061","DOI":"10.1371\/journal.pone.0059061","article-title":"CNV analysis in Tourette syndrome implicates large genomic rearrangements in COL8A1 and NRXN1","volume":"8","author":"Nag","year":"2013","journal-title":"PLoS One"},{"key":"R31-20231208","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.neuron.2017.06.010","article-title":"Rare copy number variants in NRXN1 and CNTN6 increase risk for Tourette syndrome","volume":"94","author":"Huang","year":"2017","journal-title":"Neuron"},{"key":"R32-20231208","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1176\/appi.ajp.2014.13101306","article-title":"Cross-disorder genome-wide analyses suggest a complex genetic relationship between Tourette's syndrome and OCD","volume":"172","author":"Yu","year":"2015","journal-title":"Am J Psychiatry"},{"key":"R33-20231208","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.neuron.2017.04.024","article-title":"De novo coding variants are strongly associated with Tourette disorder","volume":"94","author":"Willsey","year":"2017","journal-title":"Neuron"},{"key":"R34-20231208","article-title":"Investigation of previously implicated genetic variants in chronic tic disorders: a transmission disequilibrium test approach","author":"Abdulkadir","year":"2017","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"R35-20231208","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3389\/fnins.2016.00246","article-title":"The first world congress on Tourette syndrome and tic disorders: controversies and hot topics in etiology and treatment","volume":"10","author":"Mathews","year":"2016","journal-title":"Front Neurosci"},{"key":"R36-20231208","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpsychires.2016.11.004","article-title":"Gilles de la Tourette syndrome is associated with hypermethylation of the dopamine D2 receptor gene","volume":"86","author":"Muller-Vahl","year":"2017","journal-title":"J Psychiatr Res"},{"key":"R37-20231208","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3389\/fnins.2016.00277","article-title":"From genetics to epigenetics: new perspectives in Tourette syndrome research","volume":"10","author":"Pagliaroli","year":"2016","journal-title":"Front Neurosci"},{"key":"R38-20231208","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1017\/thg.2015.72","article-title":"Epigenome-wide association study of tic disorders","volume":"18","author":"Zilhao","year":"2015","journal-title":"Twin Res Hum Genet"},{"key":"R39-20231208","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1176\/appi.ajp.2016.16020240","article-title":"Identification of two heritable cross-disorder endophenotypes for Tourette syndrome","volume":"174","author":"Darrow","year":"2017","journal-title":"Am J Psychiatry"},{"key":"R40-20231208","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1212\/WNL.0000000000002910","article-title":"Social disinhibition is a heritable subphenotype of tics in Tourette syndrome","volume":"87","author":"Hirschtritt","year":"2016","journal-title":"Neurology"},{"key":"R41-20231208","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1176\/ajp.155.2.264","article-title":"Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases","volume":"155","author":"Swedo","year":"1998","journal-title":"Am J Psychiatry"},{"key":"R42-20231208","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/cap.2014.0084","article-title":"Clinical evaluation of youth with pediatric acute-onset neuropsychiatric syndrome (PANS): recommendations from the 2013 PANS Consensus Conference","volume":"25","author":"Chang","year":"2015","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"R43-20231208","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jneuroim.2010.08.017","article-title":"Maternal history of autoimmune disease in children presenting with tics and\/or obsessive\u2013compulsive disorder","volume":"229","author":"Murphy","year":"2010","journal-title":"J Neuroimmunol"},{"key":"R44-20231208","doi-asserted-by":"crossref","DOI":"10.1089\/cap.2016.0190","article-title":"A double-blind randomized placebo-controlled pilot study of azithromycin in youth with acute-onset obsessive\u2013compulsive disorder","author":"Murphy","year":"2017","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"R45-20231208","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S0140-6736(98)12297-3","article-title":"Therapeutic plasma exchange and intravenous immunoglobulin for obsessive\u2013compulsive disorder and tic disorders in childhood","volume":"354","author":"Perlmutter","year":"1999","journal-title":"Lancet"},{"key":"R46-20231208","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.jaac.2016.06.017","article-title":"Randomized, controlled trial of intravenous immunoglobulin for pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections","volume":"55","author":"Williams","year":"2016","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"R47-20231208","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/mp.2011.165","article-title":"A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures","volume":"17","author":"Rossignol","year":"2012","journal-title":"Mol Psychiatry"},{"key":"R48-20231208","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jaac.2017.03.013","article-title":"What is the male-to-female ratio in autism spectrum disorder? A systematic review and meta-analysis","volume":"56","author":"Loomes","year":"2017","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"R49-20231208","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s12974-014-0187-2","article-title":"Cytokine profiles by peripheral blood monocytes are associated with changes in behavioral symptoms following immune insults in a subset of ASD subjects: an inflammatory subtype?","volume":"11","author":"Jyonouchi","year":"2014","journal-title":"J Neuroinflammation"},{"key":"R50-20231208","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1136\/jmedgenet-2016-104487","article-title":"Genetics implicate common mechanisms in autism and schizophrenia: synaptic activity and immunity","volume":"54","author":"Liu","year":"2017","journal-title":"J Med Genet"},{"key":"R51-20231208","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.jaac.2015.03.008","article-title":"Maternal history of autoimmune disease and later development of tourette syndrome in offspring","volume":"54","author":"Dalsgaard","year":"2015","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"R52-20231208","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.bbr.2015.08.035","article-title":"Maternal autoimmune diseases and the risk of autism spectrum disorders in offspring: A systematic review and meta-analysis","volume":"296","author":"Chen","year":"2016","journal-title":"Behav Brain Res"},{"key":"R53-20231208","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.biopsych.2004.12.004","article-title":"Increased serum levels of interleukin-12 and tumor necrosis factor-alpha in Tourette's syndrome","volume":"57","author":"Leckman","year":"2005","journal-title":"Biol Psychiatry"},{"key":"R54-20231208","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s12264-017-0103-8","article-title":"The immune system, cytokines, and biomarkers in autism spectrum disorder","volume":"33","author":"Masi","year":"2017","journal-title":"Neurosci Bull"},{"key":"R55-20231208","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jpsychires.2008.03.012","article-title":"Age-related gene expression in Tourette syndrome","volume":"43","author":"Lit","year":"2009","journal-title":"J Psychiatr Res"},{"key":"R56-20231208","first-page":"601","article-title":"Variation in gene expression in autism spectrum disorders: an extensive review of transcriptomic studies","volume":"10","author":"Ansel","year":"2016","journal-title":"Front Neurosci"},{"key":"R57-20231208","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/ana.20315","article-title":"Neuroglial activation and neuroinflammation in the brain of patients with autism","volume":"57","author":"Vargas","year":"2005","journal-title":"Ann Neurol"},{"key":"R58-20231208","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.neubiorev.2013.01.007","article-title":"Immune-mediated animal models of Tourette syndrome","volume":"37","author":"Hornig","year":"2013","journal-title":"Neurosci Biobehav Rev"},{"key":"R59-20231208","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1126\/science.aag3194","article-title":"Maternal immune activation: implications for neuropsychiatric disorders","volume":"353","author":"Estes","year":"2016","journal-title":"Science"},{"key":"R60-20231208","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1542\/peds.2007-2658","article-title":"Serial immune markers do not correlate with clinical exacerbations in pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections","volume":"121","author":"Singer","year":"2008","journal-title":"Pediatrics"},{"key":"R61-20231208","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.brainres.2014.04.027","article-title":"The role of immune mechanisms in Tourette syndrome","volume":"1617","author":"Martino","year":"2015","journal-title":"Brain Res"},{"key":"R62-20231208","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3109\/15622975.2014.907503","article-title":"Impaired activation of the innate immune response to bacterial challenge in Tourette syndrome","volume":"15","author":"Weidinger","year":"2014","journal-title":"World J Biol Psychiatry"},{"key":"R63-20231208","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.biopsych.2006.06.012","article-title":"Decreased numbers of regulatory T cells suggest impaired immune tolerance in children with tourette syndrome: a preliminary study","volume":"61","author":"Kawikova","year":"2007","journal-title":"Biol Psychiatry"},{"key":"R64-20231208","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.bbi.2010.12.003","article-title":"Altered immunoglobulin profiles in children with Tourette syndrome","volume":"25","author":"Bos-Veneman","year":"2011","journal-title":"Brain Behav Immun"},{"key":"R65-20231208","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jns.2005.03.032","article-title":"Soluble adhesion molecules in Gilles de la Tourette's syndrome","volume":"234","author":"Martino","year":"2005","journal-title":"J Neurol Sci"},{"key":"R66-20231208","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/mds.23403","article-title":"Oligoclonal bands in cerebrospinal fluid in patients with Tourette's syndrome","volume":"26","author":"Wenzel","year":"2011","journal-title":"Mov Disord"},{"key":"R67-20231208","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1001\/jamapsychiatry.2017.0995","article-title":"Association of streptococcal throat infection with mental disorders: testing key aspects of the PANDAS hypothesis in a nationwide study","volume":"74","author":"Orlovska","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"R68-20231208","doi-asserted-by":"crossref","first-page":"e3347","DOI":"10.1097\/MD.0000000000003347","article-title":"Association of tic disorders and enterovirus infection: a nationwide population-based study","volume":"95","author":"Tsai","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"R69-20231208","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.neubiorev.2012.10.010","article-title":"Environmental factors in Tourette syndrome","volume":"37","author":"Hoekstra","year":"2013","journal-title":"Neurosci Biobehav Rev"},{"key":"R70-20231208","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00787-011-0163-7","article-title":"European clinical guidelines for Tourette syndrome and other tic disorders. Part II: Pharmacological treatment","volume":"20","author":"Roessner","year":"2011","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"R71-20231208","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.jaac.2013.09.015","article-title":"Practice parameter for the assessment and treatment of children and adolescents with tic disorders","volume":"52","author":"Murphy","year":"2013","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"R72-20231208","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/mdc3.12428","article-title":"Tics in the pediatric population: pragmatic management","volume":"4","author":"Ganos","year":"2017","journal-title":"Mov Disord Clin Pract"},{"key":"R73-20231208","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/00004583-200203000-00013","article-title":"Risperidone versus clonidine in the treatment of children and adolescents with Tourette's syndrome","volume":"41","author":"Gaffney","year":"2002","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"R74-20231208","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.neubiorev.2012.09.008","article-title":"Systematic review: pharmacological treatment of tic disorders \u2013 efficacy of antipsychotic and alpha-2 adrenergic agonist agents","volume":"37","author":"Weisman","year":"2013","journal-title":"Neurosci Biobehav Rev"},{"key":"R75-20231208","doi-asserted-by":"crossref","first-page":"422","DOI":"10.5334\/tohm.287","article-title":"Deutetrabenazine in tics associated with Tourette syndrome","volume":"6","author":"Jankovic","year":"2016","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"key":"R76-20231208","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2165\/00044011-200828070-00006","article-title":"Tourette's syndrome and role of tetrabenazine: review and personal experience","volume":"28","author":"Porta","year":"2008","journal-title":"Clin Drug Investig"},{"key":"R77-20231208","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/jnnp.2009.185348","article-title":"A randomised, double-blind, placebo-controlled study of topiramate in the treatment of Tourette syndrome","volume":"81","author":"Jankovic","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R78-20231208","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1212\/WNL.56.5.599","article-title":"Baclofen treatment in Tourette syndrome: a double-blind, placebo-controlled, crossover trial","volume":"56","author":"Singer","year":"2001","journal-title":"Neurology"},{"key":"R79-20231208","doi-asserted-by":"crossref","DOI":"10.1176\/appi.neuropsych.16110310","article-title":"Preliminary evidence on cannabis effectiveness and tolerability for adults with Tourette syndrome","author":"Abi-Jaoude","year":"2017","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"R80-20231208","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1212\/WNL.56.5.605","article-title":"Botulinum toxin for simple motor tics: a randomized, double-blind, controlled clinical trial","volume":"56","author":"Marras","year":"2001","journal-title":"Neurology"},{"key":"R81-20231208","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.brs.2015.11.005","article-title":"Deep brain stimulation for Tourette-syndrome: a systematic review and meta-analysis","volume":"9","author":"Baldermann","year":"2016","journal-title":"Brain Stimul"},{"key":"R82-20231208","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1001\/jama.2010.607","article-title":"Behavior therapy for children with Tourette disorder: a randomized controlled trial","volume":"303","author":"Piacentini","year":"2010","journal-title":"JAMA"},{"key":"R83-20231208","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1212\/WNL.0000000000003710","article-title":"Moderators and predictors of response to behavior therapy for tics in Tourette syndrome","volume":"88","author":"Sukhodolsky","year":"2017","journal-title":"Neurology"},{"key":"R84-20231208","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fpsyt.2016.00119","article-title":"The ONLINE-TICS study protocol: a randomized observer-blind clinical trial to demonstrate the efficacy and safety of internet-delivered behavioral treatment for adults with chronic tic disorders","volume":"7","author":"Jakubovski","year":"2016","journal-title":"Front Psychiatry"},{"key":"R85-20231208","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1097\/chi.0b013e31805c0860","article-title":"Immediate-release methylphenidate for ADHD in children with comorbid chronic multiple tic disorder","volume":"46","author":"Gadow","year":"2007","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"R86-20231208","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1212\/WNL.58.4.527","article-title":"Treatment of ADHD in children with tics: a randomized controlled trial","volume":"58","year":"2002","journal-title":"Neurology"},{"key":"R87-20231208","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1212\/01.wnl.0000188869.58300.a7","article-title":"Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders","volume":"65","author":"Allen","year":"2005","journal-title":"Neurology"},{"key":"R88-20231208","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.biopsych.2006.09.035","article-title":"Tics moderate treatment outcome with sertraline but not cognitive-behavior therapy in pediatric obsessive\u2013compulsive disorder","volume":"61","author":"March","year":"2007","journal-title":"Biol Psychiatry"},{"key":"R89-20231208","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.jpsychires.2013.04.003","article-title":"Antipsychotic augmentation of selective serotonin reuptake inhibitors in resistant tic-related obsessive\u2013compulsive disorder in children and adolescents: a naturalistic comparative study","volume":"47","author":"Masi","year":"2013","journal-title":"J Psychiatr Res"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00008480-201712000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T05:00:57Z","timestamp":1702011657000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008480-201712000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":88,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0000000000000546","relation":{},"ISSN":["1040-8703","1531-698X"],"issn-type":[{"value":"1040-8703","type":"print"},{"value":"1531-698X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12]]}}}